Vanguard Group Inc Jazz Pharmaceuticals PLC Transaction History

Vanguard Group Inc

$6.44 Trillion
Q3 2025

A detailed history of Vanguard Group Inc transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Vanguard Group Inc holds 5,906,945 shares of JAZZ stock, worth $833 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

5,906,945

Previous 6,090,872 3.02%

Holding current value

$833 Million

Previous $646 Million 20.45%

% of portfolio

0.01%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 07, 2025	SELL	$105.93 - $131.8 $19.5 Million - $24.2 Million	-183,927 Reduced 3.02%	5,906,945 $779 Million
Q2 2025 Aug 11, 2025	BUY	$97.78 - $126.44 $7.18 Million - $9.29 Million	73,469 Added 1.22%	6,090,872 $646 Million
Q1 2025 May 09, 2025	SELL	$120.07 - $144.17 $2.25 Million - $2.71 Million	-18,780 Reduced 0.31%	6,017,403 $747 Million
Q4 2024 Feb 11, 2025	SELL	$107.32 - $127.74 $7.65 Million - $9.11 Million	-71,326 Reduced 1.17%	6,036,183 $743 Million
Q3 2024 Nov 13, 2024	SELL	$100.57 - $116.37 $21.6 Million - $25 Million	-215,199 Reduced 3.4%	6,107,509 $681 Million

Q2 2024 Aug 13, 2024	SELL	$103.94 - $118.98 $13.1 Million - $15 Million	-125,981 Reduced 1.95%	6,322,708 $675 Million
Q1 2024 May 10, 2024	BUY	$115.19 - $132.77 $9.78 Million - $11.3 Million	84,941 Added 1.33%	6,448,689 $777 Million
Q4 2023 Feb 14, 2024	SELL	$114.26 - $136.0 $1.75 Million - $2.08 Million	-15,305 Reduced 0.24%	6,363,748 $783 Million
Q3 2023 Nov 14, 2023	BUY	$122.0 - $145.31 $3.66 Million - $4.35 Million	29,960 Added 0.47%	6,379,053 $826 Million
Q2 2023 Aug 14, 2023	BUY	$122.5 - $147.16 $21.3 Million - $25.6 Million	174,029 Added 2.82%	6,349,093 $787 Million
Q1 2023 May 15, 2023	BUY	$133.98 - $160.47 $16.7 Million - $20 Million	124,439 Added 2.06%	6,175,064 $904 Million
Q4 2022 Feb 10, 2023	BUY	$129.72 - $159.85 $21 Million - $25.9 Million	161,859 Added 2.75%	6,050,625 $964 Million
Q3 2022 Nov 14, 2022	BUY	$126.59 - $161.18 $16.7 Million - $21.2 Million	131,570 Added 2.29%	5,888,766 $785 Million
Q2 2022 Aug 12, 2022	BUY	$141.59 - $168.66 $21.9 Million - $26.1 Million	154,546 Added 2.76%	5,757,196 $898 Million
Q1 2022 May 13, 2022	BUY	$129.64 - $160.7 $7.51 Million - $9.31 Million	57,949 Added 1.05%	5,602,650 $872 Million
Q4 2021 Feb 14, 2022	BUY	$119.87 - $145.67 $7.97 Million - $9.69 Million	66,529 Added 1.21%	5,544,701 $706 Million
Q3 2021 Nov 12, 2021	SELL	$128.64 - $184.79 $682,692 - $980,680	-5,307 Reduced 0.1%	5,478,172 $713 Million
Q2 2021 Aug 13, 2021	BUY	$160.2 - $186.42 $878 Million - $1.02 Billion	5,483,479 New	5,483,479 $974 Million

Others Institutions Holding JAZZ

# of Institutions

569

Shares Held

61.8M

Call Options Held

856K

Put Options Held

178K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $8.84B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Jazz Pharmaceuticals PLC Transaction History